Please Note - Streaming News is only available to subscribers to the Active Level and above
RNS News Service
I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.
Form 38.5 (b)- Willis Towers Watson
RNS
RNS Number : 9328C
Bank of America Merrill Lynch
22 October 2020
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
Name of exempt principal trader
Bank of America, N.A., Proprietary
Company dealt in
Willis Towers Watson PLC
Class of relevant security to which the
dealings being disclosed relate(Note 1)
Common - IE00BDB6Q211
Date of dealing
21/10/2020
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 2)
Class of relevant security: Common
IE00BDB6Q211
Long
Short
Number
%
Number
%
(1)
Relevant securities
148,746
0.115%
44,874
0.035 %
(2)
Derivatives (other than options):
30,880
0.024%
46,867
0.036%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
179,626
0.139%
91,741
0.071%
(b)
Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
%
Number
%
(1)
Relevant securities
0
0%
0
0%
(2)
Derivatives (other than options):
0
0%
0
0%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3.
DEALINGS (Note 3)
(a)
Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
200
210.18 USD
Purchase
107
210.43 USD
Purchase
100
209.8 USD
Purchase
586
209.37 USD
Purchase
100
210.175 USD
Purchase
100
211.08 USD
Purchase
100
211.83 USD
Purchase
100
211.72 USD
Purchase
200
211.715 USD
Purchase
5
211.93 USD
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Sale
100
209.98 USD
Sale
92
210.27 USD
Sale
5
209.77 USD
Sale
5
209.76 USD
Sale
8
209.74 USD
Sale
151
209.91 USD
Sale
133
209.73 USD
Sale
100
209.75 USD
Sale
100
210.46 USD
Sale
29
210.23 USD
Sale
30
210.22 USD
Sale
51
209.61 USD
Sale
100
209.755 USD
Sale
100
209.615 USD
(b)
Derivatives transactions (other than options transactions)
Product name,
e.g. CFD
Nature of transaction
(Note 5)
Number of relevant securities (Note 6)
Price per unit
(Note 4)
N/A
N/A
N/A
N/A
(c)
Options transactions in respect of existing relevant securities
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call option
Number of securities
Exercise price per
unit (Note 4)
N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction (Note 7)
Details
Price per unit
(if applicable) (Note 4)
N/A
N/A
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 38.5(b) attached? (Note 8)
No
Date of disclosure
22/10/2020
Contact name
Tolu Tade
Telephone number
+44207 996 3410
Name of offeree/offeror with which connected
Willis Towers Watson PLC
Nature of connection (Note 9)
Advisor to - Willis Towers Watson PLC
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.